Trial 0006 was a randomised, double blind, multi centre study of 82 pubertal boys aged 11 18 years inclusive with gynaecomastia of greater than 12 months duration treated with Anastrozolo Actavis 1 mg day or placebo daily for up to 6 months <a href=http://finasteride.one>ciproflaxin</a>